Valuation : DIAGNOS Inc.

Market Cap 5.72Cr 4.14Cr 3.56Cr 3.35Cr 3.06Cr 391.71Cr 5.74Cr 40Cr 15Cr 200.6Cr 16Cr 15Cr 638.95Cr P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 5.67Cr 4.1Cr 3.53Cr 3.32Cr 3.03Cr 388.11Cr 5.69Cr 39Cr 15Cr 198.75Cr 15Cr 15Cr 633.09Cr EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
94.41%
Yield 2025 *
-
Yield 2026 -
1 day-1.05%
1 week-5.05%
Current month-6.00%
1 month+23.68%
3 months+118.60%
6 months+56.67%
Current year+25.33%
1 week 0.46
Extreme 0.465
0.5
1 month 0.32
Extreme 0.325
0.52
Current year 0.18
Extreme 0.175
0.52
1 year 0.18
Extreme 0.175
0.52
3 years 0.18
Extreme 0.175
0.58
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Director/Board Member 72 28/09/2020
Chairman 69 30/10/2025
Date Insider Type Main position Quantity % Market Cap. Importance
28/08/26 Buy

Director

1,05,000 0.0872%
21/08/26 Option

Director

-1,00,000 0.0830%
21/08/26 Option

Director

1,00,000 0.0830%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-5.05%+77.36%-16.07% 4.14Cr
-0.97%+0.25%-9.42%+57.07% 22TCr
-0.10%+5.95%+49.57%+104.17% 12TCr
-3.89%-4.59%-29.78%-44.86% 11TCr
-0.64%-4.79%-25.29%-34.47% 8.68TCr
-0.52%-3.12%-26.81%-6.32% 6.08TCr
-0.51%-6.40%-24.49%-26.37% 4.66TCr
-1.46%-2.43%+7.15%+100.74% 4.31TCr
-0.67%-6.70%+3.53%+184.02% 3.96TCr
-0.45%-5.51%-8.98%+1.18% 3.67TCr
Average -1.00%-2.65%+1.28%+31.91% 7.68TCr
Weighted average by Cap. -1.12%-1.51%-5.78%+35.09%

Financials

2025 2026
Net sales 1L 75.16T 64.64T 60.8T 55.5T 71.09L 1L 7L 3L 36.4L 3L 3L 1.16Cr 65.48T 47.42T 40.78T 38.35T 35.01T 44.84L 65.69T 5L 2L 22.96L 2L 2L 73.15L
Net income -42.86L -31.04L -26.69L -25.11L -22.92L -29Cr -43L -2.98Cr -1.15Cr -15Cr -1.17Cr -1.14Cr -48Cr -45.55L -32.99L -28.37L -26.68L -24.36L -31Cr -45.7L -3.16Cr -1.22Cr -16Cr -1.24Cr -1.21Cr -51Cr
Net Debt -2L -1L -1L -95.89T -87.53T -1.12Cr -2L -11.37L -4L -57.41L -4L -4L -1.83Cr -5L -4L -3L -3L -3L -3.6Cr -5L -36.47L -14.1L -1.84Cr -14.28L -13.97L -5.87Cr
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
08/26/08 CA$0.4700 -1.05% 74,018
04/26/04 CA$0.4750 -1.04% 61,732
03/26/03 CA$0.4800 +3.23% 1,88,504
02/26/02 CA$0.4650 -6.06% 2,15,280
01/26/01 CA$0.4950 -1.00% 4,93,334

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!